The responsibility rests with patients to contact CANSA for assistance. Read more...

Immunity, Knowledge, Behaviour and HPV Infection Rates after Pre-Adolescent HPV Vaccination during the VACCS 1 and 2 Trials (ImmunoVACCS)

Dr Haynes van der Merwe

Dr Haynes van der Merwe

Title of the project

Immunity, knowledge, behaviour and HPV infection rates after pre-adolescent HPV vaccination during the VACCS 1 and 2 trials (ImmunoVACCS).

Project Description

The project focuses on the reduction of risk for cervical cancer, still the most common cause of cancer death among women. Following the VACCS 1 and 2 trials by this research group, the South African National Department of Health implemented school-based HPV vaccination in public schools. The impact of pre-adolescent HPV vaccination and education on behavioural risk, immunity and resulting acquisition of different HPV types among adolescent and young South African women is however untested and unknown.

The ImmunoVACCS project will target a group of young South African women who received bivalent and quadrivalent HPV vaccines and health education via the well-published VACCS 1 and 2 projects as pre-adolescents during 2010 – 2014. The proposed project will focus on the effect of pre-adolescent HPV vaccination on three measurable aspects of cancer risk:

  • Behavioural risk tested with a questionnaire
  • Immunological risk and HPV antibodies as tested with type-specific antigen-binding tests
  • Infection risk with cancer-causing HPV types tested with molecular biology methods

This project will assist to answer some of the remaining questions about the efficacy of this risk reduction strategy, which has the potential to save many lives.

Do you have a question?
Ask CANSA
Book a counselling session

CANSA Tele Counselling

 0800 22 6622 Toll Free
 072 197 9305 English and Afrikaans
 071 867 3530 Xhosa, Zulu, Sotho and Siswati

 

info@cansa.org.za

  Find Your Care Centre

About Us | Get in Touch

Sign up to receive news and updates: